Search

Reset

Searching with a thematic focus on Intellectual Property Rights, Trade Policy

Showing 391-400 of 420 results

Pages

  • Document

    More equitable pricing for essential drugs: what do we mean and what are the issues?

    World Health Organization, 2001
    This paper examines differential pricing (also referred to as "equity pricing" or "preferential pricing"): the concept that essential drugs prices should in some way reflect countries’ ability to pay as measured by their level of income.
  • Document

    Plant variety protection to feed Africa?: Rhetoric versus reality

    GRAIN, 1999
    The Union for the Protection of New Varieties of Plants (UPOV) claim the introduction of plant variety protection (a form of patent law) will contribute to food security, sustainable agriculture, and the protection of the environment and of biodiversity.
  • Document

    Blast, biotech and big business: implications of corporate strategies on rice research in Asia

    GRAIN, 2000
    The rice blast disease and industry’s approaches to dealing with it provide a clear example of how corporate research and development (R&D) strategies are diverging from the needs and means of farmers, particularly in the poorer countries of South and Southeast Asia.
  • Document

    ISAAA in Asia: promoting corporate profits in the name of the poor

    GRAIN, 2000
    The International Service for the Acquisition of Agri-biotech Applications (ISAAA) is one of the most focused promoters of gene technologies in Asia. Through the formation and support of key local elites, ISAAA is helping carry out an agenda set by transnational corporations (TNCs), in the name of Asia’s rural poor.
  • Document

    Grains of delusion: golden rice seen from the ground

    GRAIN, 2001
    'Golden rice' is a genetically modified rice engineered to contain vitamin A or its precursor, beta-carotene. Monsanto was quick to jump on the humanitarian bandwagon by announcing royalty-free licenses for any of its technologies used to further the development of the rice.
  • Document

    Health and intellectual property rights

    World Health Organization, 2001
    Paper expresses concern that the TRIPS agreement was negotiated with little or no participation from public health authorities, and that WTO member countries are now bound to grant patents for pharmaceutical products.The paper asserts that is this respect TRIPS has caused special problems for developing countries:they are often excluded from the benefits of protection for inventions be
  • Document

    The global AIDS crisis and the first 100 days of George W. Bush’s Administration: a report card from the health gap coalition

    Global Treatment Access Campaign, 2001
    The article indicates that Bush's administration gained international attention with its decision to retain the Executive Order that affirmed the rights of sub-Saharan African countries to manufacture and import affordable generic medication without facing sanctions from the US, as they had in the past.The Health GAP coalition demands the Bush Administration:allocate $2 billion in new
  • Document

    Sui generis rights: from opposing to complementary approaches

    Biotechnology and Development Monitor, 1998
    This article provides an integrated analysis of the different concerning the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the Convention on Biological Diversity (CBD).
  • Document

    Why biotech patents are patently absurd: scientific briefing on TRIPs and related issues

    Institute of Science in Society, UK, 2001
    This scientific briefing explains why the patenting of life-forms and living processes (as covered under Article 27.3(b) of TRIPs) should be revoked and banned.Concludes that all biotech patents should be rejected on the following grounds:all involve biological processes not under the direct control of the scientist.
  • Document

    Intellectual property protection: who needs it?

    Genetic Engineering & Intellectual Property Rights Resource Center, 2001
    Addresses some of the arguments against IPR and indicates how strengthening intellectual property rights will enable farmers throughout the world to receive the latest developments in crop production.Conclusions:enforceable and strong IPRs are essential to encourage the transfer of the latest technologies to developing countries, and for stimulating research in these same new tec

Pages